Sector Chart Active Biotech AB Nasdaq Stockholm
Stocks
ACTI
SE0001137985
Biotechnology & Medical Research
|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 5.195 SEK | +0.87% |
|
-3.15% | +13.70% |
| 07-24 | Active Biotech Doses First Patient in Amended Ho172 Clinical Study of Tasquinimod in Myelofibrosis | CI |
| 07-24 | Active Biotech Doses First Patient in Amended Tasquinimod Myelofibrosis Trial | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Sector Bio Therapeutic Drugs
| Capi. | Sales Growth | Profitability | Finances | EV / Sales | P/E | |
|---|---|---|---|---|---|---|
 | 55.01B | |||||
| 54.24B | |||||
| 23.38B | - | ||||
| 22.57B | - | ||||
| 20.19B |
Select your edition
All financial news and data tailored to specific country editions
